BOIRON: First-half 2022 results – 09/07/2022 at 5:45 pm

(Data subject to a limited review by the statutory auditors)

The Board of Directors of Laboratoires BOIRON, meeting on September 7, 2022, established the half-year corporate and consolidated financial statements as of June 30, 2022.

(1)

The main information on changes in half-year revenue was the subject of a financial notice on July 21, 2022 ( https://www.boironfinance.fr/communiques/chiffre-d-affaires ).

(2)

+32.0% at constant exchange rate.

(3)

Before investment income, financing charges and taxes.

Evolution of turnover

Cumulative sales for the first half are up 35.2%. The increase was 25.2% in France, and 47.6% internationally, where it covers all geographical areas and all products. It is split more or less evenly between historic homeopathic specialties and new products.

Sales of new products launched since 2020 amounted to approximately 47 million euros, compared to 15 million euros in the first half of 2021.

This sustained growth across all geographic areas is the result of the resilience demonstrated by the Group, the result of the power of its brands, its innovation strategy, the mobilization of its teams and the flexibility of its tool. industrial.

Evolution of profitability

This increase in activity is reflected in an increase in the gross margin of €38,133k over the half-year, both in France and the United States and in the rest of the world, which goes from €134,260k in 2021 to €172k. €393 thousand in 2022.

Operating expenses increased by €7,100,000, mainly due to:

• investments in promotional expenses, up €9,220k, following the recovery of advertising costs, travel expenses and event organization in a context of improvement in the global health situation,

• and the continued decline in preparation and distribution costs, which fell by €3,360K following the 2021 reorganization.

First-half operating income thus amounted to €19,994,000, up €31,033,000 compared to the previous year.

In line with projections, disbursements for the reorganization in France in the first half of 2022 amounted to €10,663k. This amount is in addition to the €15,510,000 already disbursed in 2021.

Outlook

In a context of sustained inflation and pressure on certain supplies of energy and raw materials, we are doing everything we can to ensure the availability of our medicines and our entire range of products.

We also remain vigilant on the evolution of the global health crisis, and continue to take appropriate measures whenever necessary.

Cumulatively over the year, compared to 2021, we expect an increase in turnover in all of the Group’s geographical areas as well as a significant change in profitability.

We continue to put all our energy and determination so that every patient in the world can benefit from homeopathy and our other health solutions, in order to participate in the development of a more humane, more efficient and more sustainable health system. .

BOIRON Laboratories

The half-year accounts have been subject to a limited review by the auditors. The half-year report presenting information on activity and results for the first half of the year, as well as the outlook for 2022, was distributed in accordance with the provisions of Article 221-3 of the AMF General Regulations. It can be consulted on our company’s website (https://www.boironfinance.fr/informations-financieres/donnees-semestrielles).

Additional information on the half-year results is presented in the slides of the information meeting of Thursday, September 8, 2022 and can be consulted on our company’s website ( https://www.boironfinance.fr/informations-financieres/donnees- half-yearly).

Our next meeting: October 20, 2022: at the close of trading, publication of revenue and quarterly information as of September 30, 2022

Responsible for financial information: Valérie Lorentz-Poinsot

Financial information contact: Fabrice Rey

Shareholder relations: +33 (0) 4.37.41.84.01 – e-mail: [email protected]

ISIN Code: FR0000061129 (BOI) – Bloomberg: BOI FP – Reuters: BOIR.PA

The group’s financial information and glossary are online at: www.boironfinance.fr

© Copyright Actusnews Wire

Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com